SURGICAL ADJUVANT THERAPY FOR STAGE-II AND STAGE-III ADENOCARCINOMA AND LARGE-CELL UNDIFFERENTIATED CARCINOMA

被引：194
作者：
HOLMES, EC
GAIL, M
机构：
[1] UNIV CALIF LOS ANGELES, DEPT SURG, LOS ANGELES, CA 90024 USA
[2] NCI, BIOMETR BRANCH, BETHESDA, MD 20205 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1986年 / 4卷 / 05期
关键词：
D O I：
10.1200/JCO.1986.4.5.710
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：710 / 715
页数：6
相关论文
共 24 条
[11]  
MANTEL N, 1963, J AM STAT ASSOC, V58, P690
[12]  
MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
[13]  
MCKNEALLY MF, 1981, J THORAC CARDIOV SUR, V81, P485
[14]   ASSESSMENT OF ROLE OF SURGERY FOR CONTROL OF LUNG-CANCER [J].
MOUNTAIN, CF .
ANNALS OF THORACIC SURGERY, 1977, 24 (04) :365-373
[15]  
MOUNTAIN CF, 1981, J THORAC CARDIOV SUR, V82, P649
[16]  
NEWMAN SB, 1983, J THORAC CARDIOV SUR, V86, P180
[17]   TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP [J].
OKEN, MM ;
CREECH, RH ;
TORMEY, DC ;
HORTON, J ;
DAVIS, TE ;
MCFADDEN, ET ;
CARBONE, PP .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06) :649-655
[18]  
SHIELDS TW, 1974, ARCH SURG-CHICAGO, V109, P329
[19]  
SHIELDS TW, 1982, CANCER, V50, P1713, DOI 10.1002/1097-0142(19821101)50:9<1713::AID-CNCR2820500910>3.0.CO
[20]  
2-B
123